Cargando…

HCG Trigger of GnRH Agonist-Induced Functional Ovarian Cysts Does Not Decrease Clinical Pregnancy Rate in GnRHa Pretreated Frozen Cycles: Evidence From a Retrospective Cohort Study

BACKGROUND: GnRH agonist (GnRHa) pretreatment before the frozen-thawed embryo transfer (FET) was increasingly utilized. However, the incidence of GnRHa-induced functional ovarian cysts (FC) was inevitable. The feasibility and efficacy of HCG triggering GnRHa-induced FC are unknown. OBJECTIVE: The ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Hong, Zhang, Chen, Zhang, Lei, Liu, Nenghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240191/
https://www.ncbi.nlm.nih.gov/pubmed/35784554
http://dx.doi.org/10.3389/fendo.2022.876517
_version_ 1784737476577853440
author Zeng, Hong
Zhang, Chen
Zhang, Lei
Liu, Nenghui
author_facet Zeng, Hong
Zhang, Chen
Zhang, Lei
Liu, Nenghui
author_sort Zeng, Hong
collection PubMed
description BACKGROUND: GnRH agonist (GnRHa) pretreatment before the frozen-thawed embryo transfer (FET) was increasingly utilized. However, the incidence of GnRHa-induced functional ovarian cysts (FC) was inevitable. The feasibility and efficacy of HCG triggering GnRHa-induced FC are unknown. OBJECTIVE: The aim of the study was to investigate the effect of HCG triggering GnRHa-induced FC on FET outcomes. METHODS: A total of 657 HRT-FET cycles with GnRHa pretreatment were retrospectively analyzed. Patients were divided into the FC group and the no functional cysts (NC) group according to whether the patient developed FC (follicular diameter of ≥7 mm and E(2) of ≥100 pg/ml). Risk factors associated with the incidence of GnRHa-induced FC were determined by multivariate regression analysis. Pregnancy outcomes were compared between the FC group and the NC group. Propensity score matching (PSM) was performed to reduce the impact of confounding factors. Three multivariate regression models were performed to assess the association between HCG triggering GnRHa-induced FC and clinical pregnancy. Interactive analysis and subgroup analysis were also analyzed. RESULTS: The incidence rate of GnRHa-induced FC was 9.74%. Older age (aOR 1.10, 95% CI 1.05-1.15, p-value < 0.001) and lower BMI (aOR 0.81, 95% CI 0.71-0.93, p-value=0.002) are risk factors for GnRHa-induced FC. The implantation rate, clinical pregnancy rate (CPR), and miscarriage rate were not significantly different between the FC group and the NC group before or after PSM (p-value > 0.05). Multivariate logistic models showed that HCG triggering GnRHa-induced FC does not decrease CPR in the general population (p-value > 0.05). The effect of HCG triggering GnRHa-induced FC on clinical pregnancy is interactive with age (p-value for interaction: 0.003); HCG trigger is associated with significantly higher CPR than HRT-FET cycles without FC in patients ≥35 years (aOR 4.40, 95% CI 1.57–12.3, p-value = 0.005). CONCLUSIONS: HCG triggering GnRHa-induced FC does not decrease the chance of clinical pregnancy in HRT-FET cycles pretreated with GnRHa.
format Online
Article
Text
id pubmed-9240191
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92401912022-06-30 HCG Trigger of GnRH Agonist-Induced Functional Ovarian Cysts Does Not Decrease Clinical Pregnancy Rate in GnRHa Pretreated Frozen Cycles: Evidence From a Retrospective Cohort Study Zeng, Hong Zhang, Chen Zhang, Lei Liu, Nenghui Front Endocrinol (Lausanne) Endocrinology BACKGROUND: GnRH agonist (GnRHa) pretreatment before the frozen-thawed embryo transfer (FET) was increasingly utilized. However, the incidence of GnRHa-induced functional ovarian cysts (FC) was inevitable. The feasibility and efficacy of HCG triggering GnRHa-induced FC are unknown. OBJECTIVE: The aim of the study was to investigate the effect of HCG triggering GnRHa-induced FC on FET outcomes. METHODS: A total of 657 HRT-FET cycles with GnRHa pretreatment were retrospectively analyzed. Patients were divided into the FC group and the no functional cysts (NC) group according to whether the patient developed FC (follicular diameter of ≥7 mm and E(2) of ≥100 pg/ml). Risk factors associated with the incidence of GnRHa-induced FC were determined by multivariate regression analysis. Pregnancy outcomes were compared between the FC group and the NC group. Propensity score matching (PSM) was performed to reduce the impact of confounding factors. Three multivariate regression models were performed to assess the association between HCG triggering GnRHa-induced FC and clinical pregnancy. Interactive analysis and subgroup analysis were also analyzed. RESULTS: The incidence rate of GnRHa-induced FC was 9.74%. Older age (aOR 1.10, 95% CI 1.05-1.15, p-value < 0.001) and lower BMI (aOR 0.81, 95% CI 0.71-0.93, p-value=0.002) are risk factors for GnRHa-induced FC. The implantation rate, clinical pregnancy rate (CPR), and miscarriage rate were not significantly different between the FC group and the NC group before or after PSM (p-value > 0.05). Multivariate logistic models showed that HCG triggering GnRHa-induced FC does not decrease CPR in the general population (p-value > 0.05). The effect of HCG triggering GnRHa-induced FC on clinical pregnancy is interactive with age (p-value for interaction: 0.003); HCG trigger is associated with significantly higher CPR than HRT-FET cycles without FC in patients ≥35 years (aOR 4.40, 95% CI 1.57–12.3, p-value = 0.005). CONCLUSIONS: HCG triggering GnRHa-induced FC does not decrease the chance of clinical pregnancy in HRT-FET cycles pretreated with GnRHa. Frontiers Media S.A. 2022-06-15 /pmc/articles/PMC9240191/ /pubmed/35784554 http://dx.doi.org/10.3389/fendo.2022.876517 Text en Copyright © 2022 Zeng, Zhang, Zhang and Liu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Zeng, Hong
Zhang, Chen
Zhang, Lei
Liu, Nenghui
HCG Trigger of GnRH Agonist-Induced Functional Ovarian Cysts Does Not Decrease Clinical Pregnancy Rate in GnRHa Pretreated Frozen Cycles: Evidence From a Retrospective Cohort Study
title HCG Trigger of GnRH Agonist-Induced Functional Ovarian Cysts Does Not Decrease Clinical Pregnancy Rate in GnRHa Pretreated Frozen Cycles: Evidence From a Retrospective Cohort Study
title_full HCG Trigger of GnRH Agonist-Induced Functional Ovarian Cysts Does Not Decrease Clinical Pregnancy Rate in GnRHa Pretreated Frozen Cycles: Evidence From a Retrospective Cohort Study
title_fullStr HCG Trigger of GnRH Agonist-Induced Functional Ovarian Cysts Does Not Decrease Clinical Pregnancy Rate in GnRHa Pretreated Frozen Cycles: Evidence From a Retrospective Cohort Study
title_full_unstemmed HCG Trigger of GnRH Agonist-Induced Functional Ovarian Cysts Does Not Decrease Clinical Pregnancy Rate in GnRHa Pretreated Frozen Cycles: Evidence From a Retrospective Cohort Study
title_short HCG Trigger of GnRH Agonist-Induced Functional Ovarian Cysts Does Not Decrease Clinical Pregnancy Rate in GnRHa Pretreated Frozen Cycles: Evidence From a Retrospective Cohort Study
title_sort hcg trigger of gnrh agonist-induced functional ovarian cysts does not decrease clinical pregnancy rate in gnrha pretreated frozen cycles: evidence from a retrospective cohort study
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240191/
https://www.ncbi.nlm.nih.gov/pubmed/35784554
http://dx.doi.org/10.3389/fendo.2022.876517
work_keys_str_mv AT zenghong hcgtriggerofgnrhagonistinducedfunctionalovariancystsdoesnotdecreaseclinicalpregnancyrateingnrhapretreatedfrozencyclesevidencefromaretrospectivecohortstudy
AT zhangchen hcgtriggerofgnrhagonistinducedfunctionalovariancystsdoesnotdecreaseclinicalpregnancyrateingnrhapretreatedfrozencyclesevidencefromaretrospectivecohortstudy
AT zhanglei hcgtriggerofgnrhagonistinducedfunctionalovariancystsdoesnotdecreaseclinicalpregnancyrateingnrhapretreatedfrozencyclesevidencefromaretrospectivecohortstudy
AT liunenghui hcgtriggerofgnrhagonistinducedfunctionalovariancystsdoesnotdecreaseclinicalpregnancyrateingnrhapretreatedfrozencyclesevidencefromaretrospectivecohortstudy